Equity Analysis

Quarterly Results

    Wanbury Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524212
    INE107F01022
    0.976103
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WANBURY
    19.37
    463.68
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.31
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales145.50144.46146.29
Other Operating Income0.000.000.00
Other Income 0.690.760.62
Total Income146.19145.22146.90
Total Expenditure 124.35127.12132.94
PBIDT21.8418.1013.96
Interest 8.267.675.79
PBDT13.5810.438.18
Depreciation3.323.243.18
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.02-0.180.30
Reported Profit After Tax10.277.364.69
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item10.277.364.69
EPS (Unit Curr.)3.142.251.43
EPS (Adj) (Unit Curr.)3.142.251.43
Calculated EPS (Unit Curr.)3.142.251.43
Calculated EPS (Adj) (Unit Curr.)3.142.251.43
Calculated EPS (Ann.) (Unit Curr.)12.559.005.73
Calculated EPS (Adj) (Ann.) (Unit Curr.)12.559.005.73
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity32.7532.7432.71
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)15.0112.539.54
PBDTM(%)9.337.225.59
PATM(%)7.065.093.21
Dividend Per Share(Rs)0.000.000.00
Diluted EPS3.142.251.43